The sales of Modulators of the Genital System and Sex Hormones in Germany are forecasted to display steady growth from 2024 through 2028. In 2023, the market value stood around 544 million USD PPP. The projections show minimal year-over-year growth, with the increases in value hovering around 0.6 million USD annually. This reflects a stable market with year-on-year variations of approximately 0.1% as these consistent increments are seen across the next five-year period.

Looking forward, the following trends should be watched closely:

Potential breakthroughs in drug development that may stimulate higher growth rates.
Regulatory changes within the EU that could affect market conditions.
Societal shifts impacting demand for these products, such as population demographics and healthcare policy changes.